These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10080160)

  • 21. Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
    Lebensztejn DM; Skiba E; Sobaniec-Łotowska ME; Kaczmarski M
    Adv Med Sci; 2007; 52():114-9. PubMed ID: 18217401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMP-1/-2 and transient elastography allow non invasive diagnosis of cystic fibrosis associated liver disease.
    Rath T; Menendez KM; Kügler M; Hage L; Wenzel C; Schulz R; Graf J; Nährlich L; Roeb E; Roderfeld M
    Dig Liver Dis; 2012 Sep; 44(9):780-7. PubMed ID: 22652148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinases and their inhibitors in acute viral hepatitis.
    Koulentaki M; Valatas V; Xidakis K; Kouroumalis A; Petinaki E; Castanas E; Kouroumalis E
    J Viral Hepat; 2002 May; 9(3):189-93. PubMed ID: 12010506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders.
    Jensen MK; Holten-Andersen MN; Riisbro R; de Nully Brown P; Larsen MB; Kjeldsen L; Heickendorff L; Brünner N; Hasselbalch HC
    Eur J Haematol; 2003 Nov; 71(5):377-84. PubMed ID: 14667201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
    Lichtinghagen R; Michels D; Haberkorn CI; Arndt B; Bahr M; Flemming P; Manns MP; Boeker KH
    J Hepatol; 2001 Feb; 34(2):239-47. PubMed ID: 11281552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma matrix metalloproteinase-2 (MMP-2), tissue inhibitor of proteinase-1 (TIMP-1), TIMP-2, and urine MMP-2 concentrations correlate with proteinuria in renal transplant recipients.
    Mazanowska O; Zabińska M; Kościelska-Kasprzak K; Kamińska D; Krajewska M; Banasik M; Madziarska K; Zmonarski SC; Chudoba P; Biecek P; Boratyńska M; Klinger M
    Transplant Proc; 2014 Oct; 46(8):2636-9. PubMed ID: 25380883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selected Metal Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases as Potential Biomarkers for Tubulointerstitial Fibrosis in Children with Unilateral Hydronephrosis.
    Bieniaś B; Sikora P
    Dis Markers; 2020; 2020():9520309. PubMed ID: 32670438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
    Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
    J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B.
    Flisiak R; Al-Kadasi H; Jaroszewicz J; Prokopowicz D; Flisiak I
    World J Gastroenterol; 2004 Sep; 10(18):2661-5. PubMed ID: 15309715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1.
    Medeiros T; Saraiva GN; Moraes LA; Gomes AC; Lacerda GS; Leite PE; Esberard EB; Andrade TG; Xavier AR; Quírico-Santos T; Rosário NF; Silva AA
    Dig Liver Dis; 2020 Oct; 52(10):1170-1177. PubMed ID: 32522433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.
    Gohji K; Fujimoto N; Ohkawa J; Fujii A; Nakajima M
    Br J Cancer; 1998 Feb; 77(4):650-5. PubMed ID: 9484825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.